Advertisement
Brief observation| Volume 118, ISSUE 5, P544-547, May 2005

Download started.

Ok

Incidence and prognosis of acute heart failure in the thrombotic microangiopathies

      The thrombotic microangiopathies, which include thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome, cause microangiopathic hemolytic anemia, thrombocytopenia, and ischemic events due to the presence of microvascular occlusive platelet thrombi.
      • Moake J.L.
      Thrombotic microangiopathies.
      Associated mortality exceeded 90% before the introduction of plasma exchange therapy in the 1970s and still remains as high as 20%.
      • Elliott M.A.
      • Nichols W.L.
      Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
      Based on our clinical experience, we hypothesized that high mortality may be partly due to development of heart failure. However, symptomatic cardiac involvement in patients with thrombotic microangiopathies is infrequently reported despite pathological studies demonstrating cardiac microthrombi.
      • Berkowitz L.R.
      • Dalldor F.G.
      • Blatt P.
      Thrombotic thrombocytopenic purpura a pathology review.
      • Cuttner J.
      Thrombotic thrombocytopenic purpura a ten-year experience.
      • Eagle K.A.
      • Fallon J.T.
      Weekly clinicopathological exercises: case 33-1994: A 41-year-old woman with thrombocytopenia, anemia, and sudden death.
      • Ridolfi R.L.
      • Hutchins G.M.
      • Bell W.R.
      The heart and cardiac conduction system in thrombotic thrombocytopenic purpura.
      • Ridolfi R.L.
      • Bell W.R.
      Thrombotic thrombocytopenic purpura report of 25 cases and review of the literature.
      The aims of this study were to determine the incidence of acute heart failure in adults with thrombotic microangiopathies, its natural history, severity and reversibility of systolic dysfunction, and associated mortality rate.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Moake J.L.
        Thrombotic microangiopathies.
        N Engl J Med. 2002; 347: 589-600
        • Elliott M.A.
        • Nichols W.L.
        Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
        Mayo Clin Proc. 2001; 76: 1154-1162
        • Berkowitz L.R.
        • Dalldor F.G.
        • Blatt P.
        Thrombotic thrombocytopenic purpura.
        JAMA. 1979; 241: 1709-1710
        • Cuttner J.
        Thrombotic thrombocytopenic purpura.
        Blood. 1980; 56: 302-306
        • Eagle K.A.
        • Fallon J.T.
        Weekly clinicopathological exercises: case 33-1994: A 41-year-old woman with thrombocytopenia, anemia, and sudden death.
        N Engl J Med. 1994; 331: 661-667
        • Ridolfi R.L.
        • Hutchins G.M.
        • Bell W.R.
        The heart and cardiac conduction system in thrombotic thrombocytopenic purpura.
        Ann Intern Med. 1979; 91: 357-363
        • Ridolfi R.L.
        • Bell W.R.
        Thrombotic thrombocytopenic purpura.
        Medicine. 1981; 60: 413-428
        • McKee P.A.
        • Castello W.P.
        • McNamara P.M.
        • et al.
        The natural history of heart failure.
        N Engl J Med. 1971; 285: 1441-1446
        • Webb J.
        • Butany J.
        • Langer G.
        • et al.
        Myocarditis and myocardial hemorrhage associated with thrombotic thrombocytopenic purpura.
        Arch Intern Med. 1990; 150: 1535-1537
        • Podolsky S.H.
        • Zembowicz A.
        • Schoen F.J.
        • et al.
        Massive myocardial necrosis in thrombotic thrombocytopenic purpura.
        Arch Pathol Lab Med. 1999; 123: 937-940
        • James T.N.
        • Monto R.W.
        Pathology of the cardiac conduction system in thrombotic thrombocytopenic purpura.
        Ann Intern Med. 1966; 65: 37-43
        • Ruggenenti P.
        • Remuzzi G.
        Thrombotic thrombocytopenic purpura and related disorders.
        Hematol Oncol Clin North Am. 1990; 4: 219-241
        • Wajima T.
        • Johnson E.H.
        Sudden cardiac death from thrombotic thrombocytopenic purpura.
        Clin Appl Thromb Hemost. 2000; 6: 108-110
        • Bhimma R.
        • Rollins N.C.
        • Coovadia H.M.
        • et al.
        Post-dysenteric hemolytic uremic syndrome in children during an epidemic of shigella dysentery in kwazulu/natal.
        Pediatr Nephrol. 1997; 11: 560-564
        • Poulton J.
        • Taylor C.M.
        • De Giovanni J.V.
        Dilated cardiomyopathy associated with haemolytic uraemic syndrome.
        Br Heart J. 1987; 57: 181-183
        • Neuhaus T.J.
        • Calonder S.
        • Leumann E.P.
        Heterogeneity of atypical haemolytic uraemic syndromes.
        Arch Dis Child. 1997; 76: 518-521
        • Eckart P.
        • Guillot M.
        • Jokic M.
        • et al.
        Cardiac involvement during classic hemolytic uremic syndrome (French).
        Arch Pediatr. 1999; 6: 430-433
        • Fonarow G.C.
        Pharmacologic therapies for acutely decompensated heart failure.
        Rev Cardiovasc Med. 2002; 3: S18-S27
        • Siegler R.L.
        Cardiovascular involvement in the hemolytic uremic syndrome.
        in: Kaplan B.S. Trompeter R.S. Moake J.L. Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. Marcel Dekker, Inc, New York, New York1992: 143-149